2024's Top Biotech Pick? (ad) |
|
AI Detects Profit Surge On Monday (ad) |
|
- Alcon (NYSE:ALC) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating.The current price is $97.34.
- CrossFirst Bankshares (NASDAQ:CFB) was upgraded by analysts at Janney Montgomery Scott from a "neutral" rating to a "buy" rating. They now have a $21.00 price target on the stock. This represents a 25.1% upside from the current price of $16.78.
- CNS Pharmaceuticals (NASDAQ:CNSP) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $0.50 price target on the stock. This represents a 206.6% upside from the current price of $0.16.
- Delek US (NYSE:DK) was upgraded by analysts at JPMorgan Chase & Co. from an "underweight" rating to a "neutral" rating. They now have a $26.00 price target on the stock, up previously from $23.00. This represents a 36.3% upside from the current price of $19.08.
- DraftKings (NASDAQ:DKNG) was upgraded by analysts at BNP Paribas from an "underperform" rating to a "neutral" rating. They now have a $35.00 price target on the stock. This represents a 4.4% downside from the current price of $36.60.
- Equity Residential (NYSE:EQR) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $83.00 price target on the stock, up previously from $62.00. This represents a 9.2% upside from the current price of $76.00.
- Johnson Controls International (NYSE:JCI) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $80.00 price target on the stock, up previously from $76.00. This represents a 14.4% upside from the current price of $69.90.
- Oracle (NYSE:ORCL) was upgraded by analysts at JMP Securities from a "market perform" rating to an "outperform" rating. They now have a $175.00 price target on the stock. This represents a 11.6% upside from the current price of $156.88.
- Relay Therapeutics (NASDAQ:RLAY) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $16.00 price target on the stock, up previously from $10.60. This represents a 97.5% upside from the current price of $8.10.
- View today's most recent analysts' upgrades at MarketBeat.com

917 Trades… Zero Losses? (ad) |
If you want to learn how A Group of traders Made 917 Trades Without A Single Loss! And How You Could Have Consistently Beat the Market by following them...
Just click this link and follow along |
|
- ASOS (OTCMKTS:ASOMF) was downgraded by analysts at Barclays PLC from an "equal weight" rating to an "underweight" rating.The current price is $4.65.
- Bionano Genomics (NASDAQ:BNGO) was downgraded by analysts at BTIG Research from a "buy" rating to a "neutral" rating.The current price is $0.42.
- Coca-Cola Europacific Partners (NASDAQ:CCEP) was downgraded by analysts at BNP Paribas from an "outperform" rating to a "neutral" rating. They now have a $81.00 price target on the stock. This represents a 1.0% upside from the current price of $80.23.
- Costco Wholesale (NASDAQ:COST) was downgraded by analysts at Redburn Atlantic from a "buy" rating to a "neutral" rating. They now have a $890.00 price target on the stock, up previously from $860.00. This represents a 0.9% downside from the current price of $897.92.
- Deutsche Telekom (OTCMKTS:DTEGY) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.The current price is $28.97.
- Methanex (NASDAQ:MEOH) (TSE:MX) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating. They now have a $44.00 price target on the stock, down previously from $56.00. This represents a 18.0% upside from the current price of $37.28.
- Nutrien (NYSE:NTR) was downgraded by analysts at The Goldman Sachs Group, Inc. from a "buy" rating to a "neutral" rating. They now have a $53.00 price target on the stock, down previously from $69.00. This represents a 17.8% upside from the current price of $44.99.
- Rémy Cointreau (OTCMKTS:REMYF) was downgraded by analysts at BNP Paribas from an "outperform" rating to a "neutral" rating.The current price is $81.20.
- Relay Therapeutics (NASDAQ:RLAY) was downgraded by analysts at Oppenheimer Holdings Inc. from an "outperform" rating to a "market perform" rating.The current price is $8.10.
- View today's most recent analysts' downgrades at MarketBeat.com

Can Apple's AI News Make You Rich? (ad) |
September 20th 2024: AI's "iPhone Moment"
Apple is making a major move on Friday, September 20th. And what they're doing could be bigger than the launch of the first iPhone. Destroying and creating fortunes in the process.
Click here right now to see how to potentially profit. |
|
- Great Ajax (NYSE:AJX) is now covered by analysts at BTIG Research. They set a "neutral" rating on the stock.The current price is $3.43.
- A.P. Møller - Mærsk A/S (OTCMKTS:AMKBY) is now covered by analysts at JPMorgan Chase & Co.. They set an "underweight" rating on the stock.The current price is $7.06.
- Butterfly Network (NYSE:BFLY) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $3.00 price target on the stock. This represents a 60.5% upside from the current price of $1.87.
- CubeSmart (NYSE:CUBE) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $56.00 price target on the stock. This represents a 6.2% upside from the current price of $52.75.
- CVRx (NASDAQ:CVRX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $14.00 price target on the stock. This represents a 71.8% upside from the current price of $8.15.
- Dell Technologies (NYSE:DELL) is now covered by analysts at Susquehanna. They set a "neutral" rating and a $120.00 price target on the stock. This represents a 13.0% upside from the current price of $106.16.
- Estée Lauder Companies (NYSE:EL) is now covered by analysts at B. Riley. They set a "neutral" rating and a $95.00 price target on the stock. This represents a 11.9% upside from the current price of $84.87.
- e.l.f. Beauty (NYSE:ELF) is now covered by analysts at B. Riley. They set a "buy" rating and a $175.00 price target on the stock. This represents a 56.3% upside from the current price of $112.00.
- Extra Space Storage (NYSE:EXR) is now covered by analysts at Royal Bank of Canada. They set a "sector perform" rating and a $180.00 price target on the stock. This represents a 2.2% upside from the current price of $176.20.
- General Electric (NYSE:GE) is now covered by analysts at Sanford C. Bernstein. They set an "outperform" rating and a $201.00 price target on the stock. This represents a 21.0% upside from the current price of $166.18.
- Alphabet (NASDAQ:GOOGL) is now covered by analysts at DA Davidson. They set a "neutral" rating and a $170.00 price target on the stock. This represents a 13.8% upside from the current price of $149.44.
- Haemonetics (NYSE:HAE) is now covered by analysts at BTIG Research. They set a "buy" rating and a $112.00 price target on the stock. This represents a 52.6% upside from the current price of $73.40.
- Honest (NASDAQ:HNST) is now covered by analysts at B. Riley. They set a "buy" rating and a $6.50 price target on the stock. This represents a 57.4% upside from the current price of $4.13.
- Hapag-Lloyd Aktiengesellschaft (OTCMKTS:HPGLY) is now covered by analysts at JPMorgan Chase & Co.. They set an "underweight" rating on the stock.The current price is $73.57.
- Harmony Biosciences (NASDAQ:HRMY) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $56.00 price target on the stock. This represents a 49.7% upside from the current price of $37.42.
- Kura Sushi USA (NASDAQ:KRUS) is now covered by analysts at Northcoast Research. They set a "buy" rating and a $79.00 price target on the stock. This represents a 26.0% upside from the current price of $62.71.
- Longboard Pharmaceuticals (NASDAQ:LBPH) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $60.00 price target on the stock. This represents a 65.7% upside from the current price of $36.22.
- Meta Platforms (NASDAQ:META) is now covered by analysts at DA Davidson. They set a "buy" rating and a $600.00 price target on the stock. This represents a 19.1% upside from the current price of $503.67.
- MKS Instruments (NASDAQ:MKSI) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $140.00 price target on the stock. This represents a 31.7% upside from the current price of $106.32.
- Phibro Animal Health (NASDAQ:PAHC) is now covered by analysts at JPMorgan Chase & Co.. They set a "neutral" rating and a $22.00 price target on the stock. This represents a 7.1% upside from the current price of $20.54.
- ProKidney (NASDAQ:PROK) is now covered by analysts at Guggenheim. They set a "buy" rating and a $6.00 price target on the stock. This represents a 153.2% upside from the current price of $2.37.
- Public Storage (NYSE:PSA) is now covered by analysts at Royal Bank of Canada. They set a "sector perform" rating and a $358.00 price target on the stock. This represents a 1.0% upside from the current price of $354.48.
- Relay Therapeutics (NASDAQ:RLAY) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $20.00 price target on the stock. This represents a 146.9% upside from the current price of $8.10.
- Skye Bioscience (NASDAQ:SKYE) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $15.00 price target on the stock. This represents a 123.2% upside from the current price of $6.72.
- SKYX Platforms (NASDAQ:SKYX) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $2.00 price target on the stock. This represents a 142.3% upside from the current price of $0.83.
- Similarweb (NYSE:SMWB) is now covered by analysts at Northland Securities. They set an "outperform" rating and a $15.00 price target on the stock. This represents a 63.4% upside from the current price of $9.18.
- Stryker (NYSE:SYK) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $405.00 price target on the stock. This represents a 11.0% upside from the current price of $364.94.
- Ulta Beauty (NASDAQ:ULTA) is now covered by analysts at B. Riley. They set a "sell" rating and a $300.00 price target on the stock. This represents a 17.2% downside from the current price of $362.41.
- Zimmer Biomet (NYSE:ZBH) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $104.60.
- View today's most recent analysts' new coverage at MarketBeat.com

Get 30 Days of MarketBeat All Access Free | Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: |
| - Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. - Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. - Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.
| START YOUR 30-DAY FREE TRIAL  |
|
Upgrade Your Subscription |
Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. UPGRADE NOW  |
|
View and add up to five holdings to your watchlist.
VIEW MY PORTFOLIO  |
|
Join MarketBeat's free stock discussion and trading idea group on Facebook.
JOIN NOW  |
|
|
Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com. If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails. © 2006-2024 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103 . United States. Today's Bonus Content: I want to be very real with you (Click to Opt-in)  |